Abstract
The early response gene IEX-1 modulates apoptosis and cell growth in a poorly defined fashion. Here, we describe the effect of hammerhead ribozymes specifically disrupting IEX-1 expression in 293 cells. Compared to vector control, 293 cells exhibit a reduced growth rate and a slowed cell cycle progression, when stably transfected with a concatemeric ribozyme construct. In addition, these 293 cells were much less sensitive to apoptosis induced by an activating Fas/CD95 antibody or by the anti-cancer drugs etoposide and doxorubicin. By modulating the cell cycle, IEX-1 might be part of a growth signal if favourable growth conditions prevail, whereas under unfavourable conditions, i.e. death receptor activation, IEX-1 facilitates apoptosis.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents / pharmacology
-
Apoptosis / drug effects
-
Apoptosis Regulatory Proteins
-
Base Sequence
-
Cell Division / drug effects
-
Cell Line
-
Doxorubicin / pharmacology
-
Etoposide / pharmacology
-
Humans
-
Immediate-Early Proteins / biosynthesis
-
Immediate-Early Proteins / genetics
-
Immediate-Early Proteins / metabolism*
-
Membrane Glycoproteins / biosynthesis
-
Membrane Glycoproteins / genetics
-
Membrane Glycoproteins / metabolism*
-
Membrane Proteins
-
Neoplasm Proteins*
-
RNA, Catalytic / chemistry
-
RNA, Catalytic / genetics
-
RNA, Catalytic / metabolism*
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Templates, Genetic
-
Transfection
-
fas Receptor / metabolism
Substances
-
Antineoplastic Agents
-
Apoptosis Regulatory Proteins
-
IER3 protein, human
-
Immediate-Early Proteins
-
Membrane Glycoproteins
-
Membrane Proteins
-
Neoplasm Proteins
-
RNA, Catalytic
-
RNA, Messenger
-
fas Receptor
-
Etoposide
-
Doxorubicin